You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Correction: Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity

https://doi.org/10.1136/jitc-2023-007624corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Bhoopathi P, Kumar A, Pradhan AK, et al. Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. J Immunother Cancer 2023;11:e007624. doi: 10.1136/jitc-2023-007624

    An incorrect set of Western blots were used for XIAP and beta-actin samples in mPDX KPC (Fig 1B left panel) when preparing Fig. 1B. The original Western blots were located, and a corrected Fig. 1B is now provided.